Frantisek Antos

Frantisek Antos

Auto-generated profile, based on publicly available information

Frantisek Antos

Department of Surgery, Faculty Hospital Na Bulovce, Praha, Czech Republic

Research Focus & Metrics

Academic Career Length

50Years (1977-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2009 in Clinical Nutrition
Verified
Journal Article
Closed access
ZŠZuzana Šerclová
Zuzana Šerclová
PDPetr Dytrych
Petr Dytrych
JMJaroslav Marvan
Jaroslav Marvan
KNKateřina Nová
Kateřina Nová
ZHZuzana Hankeová
Zuzana Hankeová
FAFrantišek Antoš
František Antoš

12 July 2007 in European Surgical Research
Verified
Journal Article
Closed access
JPJiri Paral
Jiri Paral
AFA. Ferko
A. Ferko
JVJ. Varga
J. Varga
FAF. Antos
F. Antos
MPM. Plodr
M. Plodr
ZSZ. Subrt
Z. Subrt
Purpose: The aim of this prospective randomized study was to investigate the necessity of suturing subcutaneous fat tissue in elective abdominal surgery. Methods: 415 patients undergoing elective abdominal surgery were admitted to the trial. The patients were divided into two basic groups according to wound contamination: clean operations (n = 201) and clean-contaminated operation (n = 214). Subcutaneous suturing of the subcutaneous fat tissue was performed in half of the patients in each group, determined using the envelope method (‘Suture Yes’ or ‘Suture No’). Wounds were checked on postoperative days 3, 7, 14, and 30. Infectious and non-infectious wound complications were charted in the records. Data were statistically analyzed. The percentages of complications in groups with and without subcutaneous suturing were statistically compared using Yates’ corrected χ2 two-tailed test. Results: There were no statistically significant group differences in infectious and non-infectious wound complications. Conclusion: These results suggest that omission of subcutaneous fat tissue suturing does not increase the occurrence of infectious or non-infectious wound complications.

1 June 2012 in Acta Cirurgica Brasileira
Verified
Journal Article
Open access
PDF file
DHDavid Hoskovec
David Hoskovec
JVJozef Varga
Jozef Varga
EKEllen Konečná
Ellen Konečná
FAFrantišek Antoš
František Antoš
PURPOSE: Tumor markers are substances found in blood and other biological fluids if tumor is present in the body. They can be produced by tumor itself or can be results of cancer - body relation. They may be used in the follow-up of cancer patients to identify tumor recurrence. Pre-treatment levels have prognostic tool and could signalize persistence of minimal residual disease despite radical surgery. METHODS: We operated on 52 patients with upper GI malignancy (32 with gastric cancer and 20 with pancreatic cancer). Blood samples were taken before surgery and peritoneal samples immediately after laparotomy before any manipulation with tumor. All samples were examined by standard biochemical technique and the level was compared with a stage of the disease. RESULTS: Patients suffering from gastric carcinoma of stage I and II had higher level of both markers in sera then in the peritoneal cavity, however most of them were within physiological range. Patients in stage III and IV had average marker levels in the peritoneal cavity higher than in sera. Number of positive findings was increasing according to the stage of the disease. The peritoneal levels of both markers varied extremely in higher stages. In patients suffering from pancreatic carcinoma the CEA levels both in sera and peritoneal cavity were parallel but peritoneal levels were slightly higher in stages III and IV. Ca 19 - 9 was more sensitive for pancreatic cancer. The percentage of positive findings was higher in sera but the level of Ca 19 - 9 was higher in the peritoneal cavity. The number of positive findings again correlated with the stage of the disease. CONCLUSIONS: Levels of tumor markers in sera could signalize inoperability of tumor (Ca 19 - 9 in cases of pancreatic carcinoma); peritoneal levels could predict R1 resection especially in gastric cancer patients and risk of early peritoneal recurrence of the disease. Difference between the levels in the peritoneum and sera may signalize the route of dissemination (hematogenous and intraperitoneal).

6 May 2013 in Videosurgery and Other Miniinvasive Techniques
Verified
Journal Article
Open access
TBTomasz Banasiewicz
Tomasz Banasiewicz
KHKarolina Horbacka
Karolina Horbacka
JKJacek Karoń
Jacek Karoń
SMStanisław Malinger
Stanisław Malinger
FAFrantisek Antos
Frantisek Antos
PKPiotr Krokowicz
Piotr Krokowicz
Introduction : Peritoneal adhesions, the fibrotic bands that form between the surfaces in the peritoneal cavity following surgery, still pose a difficult clinical challenge. Aim : To evaluate the SprayShield ™ Adhesion Barrier System (PEG ester amine solution and a buffer solution) in...

1 April 2001 in Gastroenterology
Verified
Journal Article
Closed access
MHMartina Hubaczova
Martina Hubaczova
JSJulius Spicak
Julius Spicak
FAFrantisek Antos
Frantisek Antos
IBIlona Bartova
Ilona Bartova
PCPetr Cech
Petr Cech
MZMiroslav Zavoral
Miroslav Zavoral

1 January 2013 in Bratislava Medical Journal
Verified
Journal Article
Closed access
DHDavid Hoskovec
David Hoskovec
JVJ. Varga
J. Varga
FAF. Antos
F. Antos
MKM. Kaspar
M. Kaspar
PVP. Vitek
P. Vitek
EKE. Konecna
E. Konecna
Palliative treatment of the advanced gastric cancer by means of surgery and HIPEC